AGEN
Price
$5.96
Change
-$0.08 (-1.32%)
Updated
Jul 25 closing price
Capitalization
163.4M
CCCC
Price
$2.26
Change
-$0.03 (-1.31%)
Updated
Jul 25 closing price
Capitalization
160.48M
10 days until earnings call
Interact to see
Advertisement

AGEN vs CCCC

Header iconAGEN vs CCCC Comparison
Open Charts AGEN vs CCCCBanner chart's image
Agenus
Price$5.96
Change-$0.08 (-1.32%)
Volume$943.34K
Capitalization163.4M
C4 Therapeutics
Price$2.26
Change-$0.03 (-1.31%)
Volume$570.53K
Capitalization160.48M
AGEN vs CCCC Comparison Chart in %
Loading...
AGEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CCCC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AGEN vs. CCCC commentary
Jul 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AGEN is a StrongBuy and CCCC is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 27, 2025
Stock price -- (AGEN: $5.96 vs. CCCC: $2.26)
Brand notoriety: AGEN and CCCC are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AGEN: 66% vs. CCCC: 41%
Market capitalization -- AGEN: $163.4M vs. CCCC: $160.48M
AGEN [@Biotechnology] is valued at $163.4M. CCCC’s [@Biotechnology] market capitalization is $160.48M. The market cap for tickers in the [@Biotechnology] industry ranges from $313.33B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AGEN’s FA Score shows that 0 FA rating(s) are green whileCCCC’s FA Score has 1 green FA rating(s).

  • AGEN’s FA Score: 0 green, 5 red.
  • CCCC’s FA Score: 1 green, 4 red.
According to our system of comparison, CCCC is a better buy in the long-term than AGEN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AGEN’s TA Score shows that 3 TA indicator(s) are bullish while CCCC’s TA Score has 6 bullish TA indicator(s).

  • AGEN’s TA Score: 3 bullish, 5 bearish.
  • CCCC’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, CCCC is a better buy in the short-term than AGEN.

Price Growth

AGEN (@Biotechnology) experienced а -3.09% price change this week, while CCCC (@Biotechnology) price change was -2.59% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.62%. For the same industry, the average monthly price growth was +17.39%, and the average quarterly price growth was +28.36%.

Reported Earning Dates

AGEN is expected to report earnings on May 12, 2025.

CCCC is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Biotechnology (+7.62% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AGEN($163M) and CCCC($160M) have the same market capitalization . AGEN YTD gains are higher at: 117.518 vs. CCCC (-37.222). AGEN has higher annual earnings (EBITDA): -81.06M vs. CCCC (-102.74M). CCCC has more cash in the bank: 215M vs. AGEN (18.5M). CCCC has less debt than AGEN: CCCC (64.4M) vs AGEN (92M). AGEN has higher revenues than CCCC: AGEN (99.5M) vs CCCC (39.8M).
AGENCCCCAGEN / CCCC
Capitalization163M160M102%
EBITDA-81.06M-102.74M79%
Gain YTD117.518-37.222-316%
P/E Ratio0.20N/A-
Revenue99.5M39.8M250%
Total Cash18.5M215M9%
Total Debt92M64.4M143%
FUNDAMENTALS RATINGS
AGEN: Fundamental Ratings
AGEN
OUTLOOK RATING
1..100
70
VALUATION
overvalued / fair valued / undervalued
1..100
96
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
36
P/E GROWTH RATING
1..100
97
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AGENCCCC
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
85%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
86%
MACD
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
78%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
89%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 10 days ago
84%
Bullish Trend 9 days ago
83%
Declines
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
84%
Aroon
ODDS (%)
N/A
Bullish Trend 2 days ago
77%
View a ticker or compare two or three
Interact to see
Advertisement
AGEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CCCC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VBREY7.570.28
+3.87%
Vibra Energia SA
KYOCF11.95N/A
N/A
Kyocera Corp.
ELLH13.51N/A
N/A
Elah Holdings Inc.
MKTDF0.06N/A
N/A
Deepmarkit Corp.
TNYZF0.67N/A
-0.10%
Tiny Ltd.

AGEN and

Correlation & Price change

A.I.dvisor indicates that over the last year, AGEN has been closely correlated with TAOX. These tickers have moved in lockstep 91% of the time. This A.I.-generated data suggests there is a high statistical probability that if AGEN jumps, then TAOX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AGEN
1D Price
Change %
AGEN100%
-1.32%
TAOX - AGEN
91%
Closely correlated
-5.51%
ALLR - AGEN
87%
Closely correlated
N/A
NRXP - AGEN
83%
Closely correlated
+0.33%
PALI - AGEN
81%
Closely correlated
+4.50%
CCCC - AGEN
45%
Loosely correlated
-1.31%
More

CCCC and

Correlation & Price change

A.I.dvisor indicates that over the last year, CCCC has been loosely correlated with BEAM. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if CCCC jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CCCC
1D Price
Change %
CCCC100%
-1.31%
BEAM - CCCC
54%
Loosely correlated
+3.68%
CRBU - CCCC
51%
Loosely correlated
-3.80%
PRME - CCCC
51%
Loosely correlated
-3.22%
IDYA - CCCC
50%
Loosely correlated
-1.33%
KYMR - CCCC
50%
Loosely correlated
-0.13%
More